Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial.
Saved in:
| Title: | Five-year follow-up of intracoronary autologous cell therapy in acute myocardial infarction: the REGENERATE-AMI trial. |
|---|---|
| Authors: | Mathur A; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Sim DS; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiovascular Medicine, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea., Choudry F; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Veerapen J; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Colicchia M; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Turlejski T; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Hussain M; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Hamshere S; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Locca D; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland., Rakhit R; Department of Cardiology, The Royal Free Hospital, Royal Free London Foundation Trust, London, UK., Crake T; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Kastrup J; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark., Agrawal S; Haemato-Oncology, Barts Health NHS Trust & Immunobiology, Blizard Institute, Queen Mary University of London, London, UK., Jones DA; Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, UK.; Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, UK., Martin J; University College London, London, UK. |
| Source: | ESC heart failure [ESC Heart Fail] 2022 Apr; Vol. 9 (2), pp. 1152-1159. Date of Electronic Publication: 2022 Jan 18. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2055-5822 (Electronic) Linking ISSN: 20555822 NLM ISO Abbreviation: ESC Heart Fail Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2055-5822 |
|---|---|
| DOI: | 10.1002/ehf2.13786 |
